Clinical Trial Update: Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on tisotumab vedotin with continued treatment in patients with various solid tumors, including gynecologic and other cancers; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Cervix Cancer
• Endometrium Cancer
• Esophagus Cancer
• Lung Cancer Nonsmall Cell
• Ovary Cancer
• Prostate Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Tisotumab Vedotin (tisotumab vedotin)

Snippet

Sponsor: Seagen Inc. | Conditions: Ovary Cancer, Cervix Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-11-04